First Citizens Bank & Trust CO Moderna, Inc. Transaction History

First Citizens Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $1.66 Million - $2.24 Million	-13,979 Reduced 88.36%	1,841 $223,000
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $501,942 - $728,974	3,700 Added 30.53%	15,820 $2.43 Million
Q4 2022 Jan 24, 2023	BUY	$118.38 - $210.04 $125,837 - $223,272	1,063 Added 9.61%	12,120 $2.18 Million
Q3 2022 Oct 20, 2022	SELL	$118.07 - $194.18 $457,757 - $752,835	-3,877 Reduced 25.96%	11,057 $1.31 Million
Q2 2022 Jul 26, 2022	BUY	$117.13 - $176.59 $509,398 - $767,989	4,349 Added 41.09%	14,934 $2.13 Million
Q1 2022 Apr 26, 2022	BUY	$126.46 - $235.05 $600,558 - $1.12 Million	4,749 Added 81.37%	10,585 $1.82 Million
Q4 2021 Mar 11, 2022	BUY	$225.82 - $368.51 $1.32 Million - $2.15 Million	5,836 New	5,836 $1.48 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.